# Safety and Efficacy of the Symetis ACURATE Neo/TF Compared to the Edwards SAPIEN 3 Bioprosthesis.

> **NCT03011346** · NA · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 739 (actual)

## Conditions studied

- Aortic Valve Stenosis

## Interventions

- **DEVICE:** Symetis ACURATE neo/TF transfemoral TAVI system
- **DEVICE:** Edwards Sapien 3 Transcatheter Heart Valve

## Key facts

- **NCT ID:** NCT03011346
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-08
- **Primary completion:** 2019-05-02
- **Final completion:** 2022-02-16
- **Target enrollment:** 739 (ACTUAL)
- **Last updated:** 2022-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03011346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03011346, "Safety and Efficacy of the Symetis ACURATE Neo/TF Compared to the Edwards SAPIEN 3 Bioprosthesis.". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03011346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*